Get the Stockscreener App
148.63
3.04%
4.39
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $148.63, with a volume of 429.93K.
It is up +3.04% in the last 24 hours and down -6.07% over the past month.
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$144.24
Open:
$145.12
24h Volume:
429.93K
Relative Volume:
0.64
Market Cap:
$8.07B
Revenue:
$1.97B
Net Income/Loss:
$-494.50M
P/E Ratio:
-16.12
EPS:
-9.22
Net Cash Flow:
$137.20M
1W Performance:
-3.41%
1M Performance:
-6.07%
6M Performance:
-12.55%
1Y Performance:
+21.72%
1-Day Range:
$144.28
$149.59
1-Week Range:
$143.11
$155.88
52-Week Range:
$107.98
$194.88
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
148.63 | 8.36B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Masimo Targets CBP Over Latest Apple Watch Import Ruling - Law360
Masimo's 'Empty Voting' Suit Against Founder Survives - Law360
Masimo Loses Another Board Member in an Unexpected Resignation; Motive is a Mystery - Strata-gee.com
Masimo sues US Customs over approval of Apple Watch imports - Reuters
Masimo Corporation $MASI Shares Sold by Citigroup Inc. - MarketBeat
Masimo Sues Customs Over Apple Watch’s Restored Oxygen Tool (1) - Bloomberg Law News
Versor Investments LP Invests $1.16 Million in Masimo Corporation $MASI - MarketBeat
What momentum shifts mean for Masimo Corporation2025 Breakouts & Breakdowns & Community Shared Stock Ideas - Newser
Masimo O3® Regional Oximetry Receives FDA Clearance for Expanded Indication of Its Unique Delta Hemoglobin Parameters – Company AnnouncementFT.com - Financial Times
News impact scoring models applied to Masimo CorporationWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
Signal strength of Masimo Corporation stock in tech scanners2025 Technical Patterns & Safe Capital Preservation Plans - Newser
Will Masimo Corporation rebound enough to break evenWeekly Trade Recap & Verified Technical Trade Signals - Newser
Invesco Ltd. Has $43.54 Million Position in Masimo Corporation $MASI - MarketBeat
How sentiment analysis helps forecast Masimo Corporation2025 Winners & Losers & Growth Focused Stock Pick Reports - Newser
Statistical indicators supporting Masimo Corporation’s strengthTrade Exit Report & Community Consensus Picks - Newser
Using Python tools to backtest Masimo Corporation strategies2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - Newser
Is this a good reentry point in Masimo Corporation2025 Market Sentiment & Risk Managed Trade Strategies - Newser
Can Masimo Corporation recover in the next quarterWeekly Loss Report & Accurate Intraday Trading Signals - Newser
Visual analytics tools that track Masimo Corporation performanceJuly 2025 Outlook & Growth Oriented Trade Recommendations - Newser
Risk vs reward if holding onto Masimo Corporation2025 Price Momentum & Consistent Growth Stock Picks - Newser
Real time social sentiment graph for Masimo CorporationJuly 2025 Volume & Stepwise Swing Trade Plans - Newser
Why Masimo’s Stock is Making Waves Today - TipRanks
Can Masimo Corporation disrupt its industry2025 Pullback Review & Fast Moving Stock Trade Plans - newsyoung.net
Midday Stock Roundup: Lantronix Up on New U.S. Army Partnership - Orange County Business Journal
Masimo Corporation shares rise 1.67% intraday as Apple Watch blood oxygen feature returns. - AInvest
Masimo chairman Brennan buys $30,560 in shares By Investing.com - Investing.com Canada
Masimo chairman Brennan buys $30,560 in shares - Investing.com
What's Going On With Apple Stock Thursday?Masimo (NASDAQ:MASI) - Benzinga
Oracle, Kratos, Masimo - TradingView
Jeremy Grantham's Q2 2025 13F Filing: Notable Reduction in Otis Worldwide Corp Shares and Significant Increases in Broadcom and Constellation Brands - AInvest
BTIG reiterates Buy rating on Masimo stock amid Apple blood oxygen feature return - Investing.com
BTIG reiterates Buy rating on Masimo stock amid Apple blood oxygen feature return By Investing.com - Investing.com South Africa
Apple to bring blood oxygen feature to some US watches with software update - Reuters
Elliott Wave Theory Predicts Pullback in Masimo CorporationJuly 2025 Volume & Fast Entry Momentum Trade Alerts - sundaytimes.kr
Apple Watch Blood Oxygen Tracker Back in US With Workaround - Bloomberg.com
Using AI based signals to follow Masimo CorporationBond Market & Community Verified Watchlist Alerts - Newser
Masimo Corporation (NASDAQ:MASI) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Masimo Corp Director Acquires 3,000 Shares Amidst Fair Valuation. - AInvest
Director Makes Bold Move with Major Masimo Stock Purchase - TipRanks
Masimo Corp Director Buys 3,000 Shares at $145.98 per Share on Aug 11, 2023 - AInvest
Masimo Corp Director William R Jellison Acquires 3,000 Shares - TradingView
PNC Financial Services Group Inc. Has $947,000 Position in Masimo Corporation (NASDAQ:MASI) - Defense World
Why Masimo Corporation stock is on top investor watchlistsFree Weekly Stock Watch With Growth Focus - Newser
Why Masimo Corporation stock attracts strong analyst attentionFree Price Action Based Buy Opportunity List - Newser
Mutual of America Capital Management LLC Has $3.81 Million Stock Holdings in Masimo Corporation (NASDAQ:MASI) - Defense World
Will breakout in Masimo Corporation lead to full recoveryWeekly Signal Report with Trend Summary - Newser
Masimo Reports Fiscal 2025 Q2 Results: Revenues +8%, Op Profits +54%, EPS +78%; So Why Did Its Stock Drop 12%? - Strata-gee.com
Masimo (NASDAQ:MASI) Price Target Raised to $210.00 at Piper Sandler - MarketBeat
Masimo Corporation (NASDAQ:MASI) Q2 2025 Earnings Call Transcript - Insider Monkey
Is Masimo Corporation stock reversal real or fakeChart Scanner for Swing Trade Timing - Newser
Masimo (MASI) Receives a Hold from Jefferies - The Globe and Mail
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Masimo Corp Stock (MASI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Brennan Michelle | Chairman of the Board |
Aug 12 '25 |
Buy |
150.35 |
100 |
15,035 |
7,218 |
| Jellison William R | Director |
Aug 11 '25 |
Buy |
145.98 |
3,000 |
437,940 |
4,790 |
| MASIMO CORP | 10% Owner |
Jul 01 '25 |
Sale |
2.25 |
821,327 |
1,847,986 |
0 |
| Muhsin Bilal | Chief Operating Officer |
May 12 '25 |
Option Exercise |
34.51 |
10,000 |
345,100 |
34,172 |
| Muhsin Bilal | Chief Operating Officer |
May 12 '25 |
Sale |
163.28 |
10,000 |
1,632,781 |
24,172 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):